Literature DB >> 4274413

Mixed-lymphocyte reaction as a measure of immunological competence of lymphocytes from patients with Crohn's disease.

E R Richens, M J Williams, K R Gough, R J Ancill.   

Abstract

Peripheral blood lymphocytes from 12 patients with Crohn's disease and from a group of normal volunteers have been tested for transformation under stimulation of allogeneic cells in a mixed lymphocyte culture and by phytohaemagglutinin (PHA) in vitro. There was a significant depression of transformation in the mixed lymphocyte culture where lymphocytes from the Crohn's disease patients constituted the responding population. With PHA stimulation, no difference in transformation was seen between the patients and the control group. This is interpreted as indicating a depression in cellular immunity in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4274413      PMCID: PMC1412937          DOI: 10.1136/gut.15.1.24

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

1.  Mitogenic action of phytohaemagglutinin.

Authors:  K HIRSCHHORN; R L KOLODNY; N HASHEM; F BACH
Journal:  Lancet       Date:  1963-08-10       Impact factor: 79.321

2.  Short-term lymphocyte cultures in regional enteritis.

Authors:  S M Brown; R N Taub; D H Present; H D Janowitz
Journal:  Lancet       Date:  1970-05-23       Impact factor: 79.321

3.  Leucocyte migration inhibition with Kveim antigen in Crohn's disease.

Authors:  J Brostoff; J G Walker
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

4.  Lymphocyte response to phytohemagglutinin in Hodgkin's disease.

Authors:  T Han; J E Sokal
Journal:  Am J Med       Date:  1970-06       Impact factor: 4.965

5.  Delayed hypersensitivity and lymphocyte transformation in Crohn's disease and proctocolitis.

Authors:  J G Walker; M F Greaves
Journal:  Gut       Date:  1969-05       Impact factor: 23.059

6.  Development of delayed hypersensitivity to dinitrochlorobenzene in patients with Crohn's disease.

Authors:  J V Jones; J Housley; P M Ashurst; C F Hawkins
Journal:  Gut       Date:  1969-01       Impact factor: 23.059

7.  A study of Crohn's syndrome using tissue extracts and the Kveim and Mantoux tests.

Authors:  W J Williams
Journal:  Gut       Date:  1965-10       Impact factor: 23.059

8.  In-vitro inhibition of leucocyte migration in Crohn's disease by a sarcoid spleen suspension.

Authors:  J M Willoughby; D N Mitchell
Journal:  Br Med J       Date:  1971-07-17

9.  Prednisolone inhibition of DNA synthesis by human lymphocytes induced in 1itro by phytohaemagglutinin.

Authors:  G A Caron
Journal:  Int Arch Allergy Appl Immunol       Date:  1967

10.  Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease.

Authors:  G Bendixen
Journal:  Gut       Date:  1969-08       Impact factor: 23.059

  10 in total
  16 in total

1.  The distribution of mucosal antibodies in the bowel of patients with Crohn's disease.

Authors:  F H Green; H Fox
Journal:  Gut       Date:  1975-02       Impact factor: 23.059

2.  Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Baklien; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

3.  Immune status in Crohn's disease. 2. Originally unimpaired primary cell mediated immunity in vitro.

Authors:  I O Auer; C Buschmann; E Ziemer
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

4.  Immunological studies in patients with Crohn's disease.

Authors:  B R MacPherson; R J Albertini; W L Beeken
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

5.  Impaired anamnestic cellular immune response in patients with Crohn's disease.

Authors:  S G Meuwissen; P T Schellekens; L Huismans; G N Tytgat
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

6.  Leukocyte migration test in Crohn's disease, ulcerative colitis, and ankylosing spondylitis using Crohn's colon homogenate, mitochondrial, and microsomal fractions.

Authors:  M J Williams; E R Richens; K R Gough; R J Ancill
Journal:  Am J Dig Dis       Date:  1975-05

7.  The effect of azathioprine on cell-mediated immunity (CMI) to Candida albicans in Crohn's disease.

Authors:  G M Gyte; J M Willoughby
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

Review 8.  The immunologic basis of inflammatory bowel disease.

Authors:  W Strober; S P James
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

9.  Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations.

Authors:  S G Meuwissen; T M Feltkamp-Vroom; A B De La Rivière; A E Von Dem Borne; G N Tytgat
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

10.  Enumeration of lymphocyte populations defined by surface markers in the whole blood of patients with Crohn's disease.

Authors:  E O Pepys; E A Fagan; G A Tennent; V S Chadwick; M B Pepys
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.